CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.

Autor: Gelibter, Alain1 (AUTHOR), Asquino, Angela2 (AUTHOR), Strigari, Lidia3 (AUTHOR), Zizzari, Ilaria Grazia2 (AUTHOR), Tuosto, Lucrezia2 (AUTHOR), Scirocchi, Fabio2 (AUTHOR), Pace, Angelica2 (AUTHOR), Siringo, Marco1 (AUTHOR), Tramontano, Elisa1 (AUTHOR), Bianchini, Serena4 (AUTHOR), Bellati, Filippo5 (AUTHOR), Botticelli, Andrea1 (AUTHOR), Paoli, Donatella4 (AUTHOR), Santini, Daniele1 (AUTHOR), Nuti, Marianna2 (AUTHOR), Rughetti, Aurelia2 (AUTHOR), Napoletano, Chiara2 (AUTHOR) chiara.napoletano@uniroma1.it
Zdroj: Journal of Translational Medicine. 4/3/2024, Vol. 22 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje